ENZO BIOCHEM INC ENZ Income Statement

Enzo biochem inc (ENZ)

Income statement / TTM

Jan'20	Oct'19	Jul'19	Apr'19	Jan'19	Oct'18	Jul'18	Apr'18	Jan'18	Oct'17	Jul'17	Apr'17	Jan'17	Oct'16	Jul'16	Apr'16	Jan'16	Oct'15	Jul'15	Apr'15	Jan'15	Oct'14	Jul'14	Apr'14	Jan'14	Oct'13	Jul'13	Apr'13	Jan'13	Oct'12	Jul'12	Apr'12	Jan'12	Oct'11	Jul'11	Apr'11	Jan'11	Oct'10
Revenues
80,174	80,117	81,170	83,004	88,572	95,397	101,013	105,347	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Clinical laboratory services
-	-	-	-	-	-	-	-	-	-	-	-	73,697	72,383	-	69,985	67,480	64,682	63,414	61,643	60,528	59,651	58,689	57,258	56,100	55,572	55,889	57,732	59,590	60,393	59,403	57,837	56,404	54,559	52,762	0	0	0
Product revenues
-	-	-	-	-	-	-	-	-	-	-	-	30,481	30,076	-	30,325	30,230	31,375	31,690	32,057	32,858	33,189	32,850	32,375	31,933	31,755	32,526	33,477	34,786	36,452	37,722	39,294	40,655	41,350	41,830	0	0	0
Royalty and license fee income
-	-	-	-	-	-	-	-	-	-	-	-	1,402	1,421	-	1,557	1,710	1,895	2,495	3,109	3,415	3,797	4,408	4,676	4,896	4,884	5,292	5,637	5,821	6,115	5,958	6,360	6,310	6,221	7,437	0	0	0
Total revenues
-	-	-	-	-	-	-	-	-	-	-	-	105,580	103,880	-	101,867	99,420	97,952	97,599	96,809	96,801	96,637	95,947	94,309	92,929	92,211	93,707	96,846	100,197	102,960	103,083	103,491	103,369	102,130	102,029	0	0	0
Operating costs and expenses:
Cost of revenues
57,031	58,204	57,922	58,137	58,334	59,193	60,385	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of clinical laboratory services
-	-	-	-	-	-	-	-	-	-	-	-	43,940	43,423	-	42,498	41,080	39,791	39,589	39,263	39,323	39,369	38,948	38,570	38,117	38,250	38,251	38,044	37,917	37,201	36,305	35,076	34,140	32,923	31,682	0	0	0
Cost of product revenues
-	-	-	-	-	-	-	-	-	-	-	-	14,343	14,029	-	14,554	14,487	15,099	15,183	15,101	15,122	15,169	15,320	15,549	15,968	16,246	16,584	17,703	18,173	18,715	19,668	20,936	21,442	22,668	22,137	0	0	0
Research and development
3,733	3,501	3,175	3,194	3,212	3,191	3,210	3,215	3,182	2,853	2,928	2,985	3,101	3,479	3,524	3,526	3,453	3,426	3,350	3,077	3,117	3,115	3,141	3,419	3,559	3,695	3,889	4,345	4,944	5,679	6,293	6,891	7,356	7,674	7,806	0	0	0
Selling, general and administrative
43,630	44,434	44,265	44,867	44,968	44,520	44,455	43,878	43,391	43,560	44,149	44,613	44,948	45,010	43,741	43,342	42,619	41,009	41,069	40,684	41,143	41,557	41,801	41,533	41,960	42,768	43,654	45,541	46,363	46,958	47,928	47,468	46,491	46,544	45,191	0	0	0
Provision for uncollectible accounts receivable
-	-	-	-	-	-	-	-	-	-	-	2,565	2,521	2,301	2,336	2,292	2,305	2,447	2,284	2,326	2,421	2,732	3,063	3,107	3,351	3,774	4,496	5,313	5,578	5,412	5,104	5,042	4,854	4,642	4,431	0	0	0
Legal and related expense
4,313	3,395	3,000	4,045	5,439	5,997	5,127	4,207	3,068	1,738	1,679	1,994	3,114	5,155	6,384	7,207	7,530	7,923	8,788	9,391	9,347	8,039	6,954	5,752	5,549	5,494	5,813	5,739	4,974	4,556	3,724	3,776	3,528	3,882	3,710	0	0	0
Legal settlements, net
-	-	-	0	-	-	-	-	-	-	-	-	-	-	57,250	18,620	0	0	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating costs and expenses
79,782	80,609	79,437	80,879	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating costs and expenses
-	-	-	-	-	-	-	-	112,750	110,904	-	71,568	73,167	62,947	55,925	83,681	81,566	91,437	98,805	109,672	107,373	106,881	106,127	104,830	108,504	110,227	112,687	141,225	142,489	143,061	143,562	119,189	117,811	118,333	114,957	0	0	0
Operating loss
392	-492	1,733	1,686	-23,381	-17,504	-12,164	-7,001	-4,462	-2,508	-3,148	34,668	32,413	40,933	46,848	18,186	17,854	6,515	-1,206	-12,863	-10,572	-10,244	-10,180	-10,521	-15,575	-18,016	-18,980	-44,379	-42,292	-40,101	-40,479	-15,698	-14,442	-16,203	-12,928	0	0	0
Other income (expense):
Interest, net
963	1,019	1,056	1,043	1,012	970	853	713	601	495	384	226	71	-50	-136	-191	-209	-216	-245	-223	-212	-215	-208	-189	-152	-107	-54	1	-7	14	21	-6	14	4	11	0	0	0
Other
402	462	382	331	278	179	168	142	51	42	125	104	200	187	122	154	158	130	95	136	120	152	194	14	29	57	5	65	55	77	77	-13	43	40	45	0	0	0
Foreign exchange gain (loss)
-214	-167	-682	-948	-1,078	-404	-275	586	1,195	301	135	-683	-411	-705	-474	-179	-723	-594	-936	-1,028	-759	-480	289	422	64	148	80	-178	116	-340	-540	-329	-218	70	49	0	0	0
Loss before income taxes
1,543	822	2,489	2,112	-23,169	-16,759	-11,418	-5,560	-2,615	-1,670	-2,504	34,315	32,273	40,365	46,360	17,970	17,080	5,835	-2,292	-13,978	-11,423	-10,787	-9,905	-10,274	-15,634	-17,918	-18,949	-44,491	-42,128	-40,350	-40,921	-16,046	-14,603	-16,089	-12,823	0	0	0
Benefit for income taxes
-	0	-	0	-	-1,097	-1,097	0	0	0	-	778	780	987	1,074	377	279	-43	-7	-82	21	132	72	-364	-409	-585	-712	-2,213	-2,209	-1,884	-1,652	100	242	243	137	0	0	0
Net loss
1,543	822	2,489	2,112	-23,169	-15,662	-10,321	-4,463	-1,518	-1,670	-2,504	33,537	31,493	39,378	45,286	17,593	16,801	5,878	-2,285	-13,896	-11,444	-10,919	-9,977	-9,910	-15,225	-17,333	-18,237	-42,278	-39,919	-38,466	-39,269	-16,146	-14,845	-16,332	-12,960	0	0	0
Net loss per common share:
Basic and diluted (in Dollars per share)
-0.16	-0.16	-	-	-0.18	-0.13	-	-	-0.02	-0.01	-	0.00	-0.02	-	-	-	-	-	-	-	-	-	-	-0.01	-0.09	-0.07	-0.08	-0.15	-0.14	-0.09	-0.69	-0.09	-0.11	-0.12	-0.11	-0.05	-0.15	-0.03
Basic (in Dollars per share)
-	-	-	0.47	-	-	-	-0.06	-	-	-	-	-	-0.03	0.78	-0.05	0.15	0.10	0.18	-0.06	-0.09	-0.08	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (in Dollars per share)
-	-	-	0.47	-	-	-	-0.06	-	-	-	-	-	-0.03	0.77	-0.05	0.15	0.10	0.18	-0.06	-0.09	-0.08	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Weighted average common shares outstanding:
Basic (in Shares)
-	-	-	47,452	-	-	-	47,073	-	-	-	-	-	46,272	46,266	46,201	46,077	46,068	46,059	45,797	45,000	44,564	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (in Shares)
-	-	-	47,555	-	-	-	47,073	-	-	-	-	-	46,272	47,496	46,201	46,518	46,193	46,059	45,797	45,000	44,564	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic and diluted (in Shares)
47,557	47,557	-	-	47,199	47,186	-	-	46	46	-	46	46,292	-	-	-	-	-	-	-	-	-	-	43,243	41,887	41,057	40,284	39,553	39,312	39,279	116,289	38,825	38	38	-	38,478	-	-
Basic and diluted (in Shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	38,198	38,160